Literature DB >> 7982533

Evaluation of exposure to water aerosol or air by nose-only or whole-body inhalation procedures for CD-1 mice in developmental toxicity studies.

R W Tyl1, B Ballantyne, L C Fisher, D L Fait, T A Savine, I M Pritts, D E Dodd.   

Abstract

This study was performed to evaluate the effects of nose-only restraint versus whole-body exposure procedures in the absence of test chemical, and to determine the appropriate control environment (water aerosol or air) for subsequent developmental toxicity studies of test materials administered as aerosols. Timed-pregnant CD-1 mice, 30/group, were exposed to high concentrations of water aerosol or to air by whole-body or nose-only inhalation procedures on Gestational Days (GD) 6 through 15 for 6 hr per day. The group exposed to air by whole-body procedures was designated as the control group. Clinical observations and maternal body weights were recorded throughout gestation. At scheduled necropsy on GD 18, maternal animals were evaluated for body weight, gravid uterine weight, liver weight, number of ovarian corpora lutea, and status of uterine implantation sites. Fetuses were counted, weighed, and sexed and were examined for external, visceral (including craniofacial), and skeletal alterations. Indices of maternal toxicity were affected in both nose-only groups. Maternal body weights were reduced during and after the exposure period; maternal weight gain was reduced during the exposure period. Clinical signs observed, from animals struggling during restraint, were resolved by GD 18. At sacrifice on GD 18, maternal body weights and maternal gestational weight gains (both corrected for gravid uterine weights) and absolute liver weights were reduced in both nose-only groups. Four females died (13.3%, all pregnant) in the air nose-only group, and maternal liver weight (relative to body weight) was reduced in the aerosol nose-only group. Gestational parameters were unaffected by any of the treatments. There were no statistically significant differences in the incidences of any individual malformations or malformations by category (external, visceral, or skeletal) or of total malformations. However, exencephaly, low set ears, cleft palate and ventricular septal defect were observed only in both aerosol-exposed groups (whole-body and nose-only exposed). The incidences of individual external or visceral variations or of variations by category or of total variations were unaffected. The incidence of one skeletal variation, poorly ossified supraoccipital skull bone, was significantly increased in the aerosol nose-only group relative to the air whole-body controls. There were also increased incidences (not statistically significant) of extra (14th) ribs in both aerosol groups. Therefore, maternal restraint (in both nose-only groups) during organogenesis produced indications of maternal toxicity, but restraint did not appear to affect normal embryo/fetal morphologic development.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982533     DOI: 10.1006/faat.1994.1103

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  3 in total

1.  Computer-automated silica aerosol generator and animal inhalation exposure system.

Authors:  Walter McKinney; Bean Chen; Diane Schwegler-Berry; Dave G Frazer
Journal:  Inhal Toxicol       Date:  2013-06       Impact factor: 2.724

2.  Inhalation Exposure to Carbon Nanotubes (CNT) and Carbon Nanofibers (CNF): Methodology and Dosimetry.

Authors:  Günter Oberdörster; Vincent Castranova; Bahman Asgharian; Phil Sayre
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2015       Impact factor: 6.393

Review 3.  Quantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity.

Authors:  Guillaume Boulanger; Pascal Andujar; Jean-Claude Pairon; Marie-Annick Billon-Galland; Chantal Dion; Pascal Dumortier; Patrick Brochard; Annie Sobaszek; Pierre Bartsch; Christophe Paris; Marie-Claude Jaurand
Journal:  Environ Health       Date:  2014-07-21       Impact factor: 5.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.